XAV‐939 inhibits epithelial‐mesenchymal transformation in pulmonary fibrosis induced by crystalline silica via the Wnt signaling pathway
Environmental Toxicology · 2023-02 · 38 (2) · 460-471
DOI: 10.1002/tox.23693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 28.10.2022. Verfasst von Zhihao Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Xinxiang Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pulmonary Fibrosis, Silicosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science and Technology Foundation Project, Hebei Postgraduate, Innovation Subsidy Project.
Abstract (Originalsprache)
Silicosis is an occupational lung disease that results from long‐term inhalation of free silica dust, the expression is sustained inflammation response, fibroblast hyperplasia, and excessive collagen deposit, bringing about pulmonary interstitial fibrosis. Wnt signaling pathway exists in various kinds of eukaryotic cells, is a highly conservative signaling pathway in biological evolution, and participates in cell proliferation, differentiation, migration, and polarity of physiological activity, such as in embryonic development, organ morphology, and tumor. In addition, it plays an important role in the progress of fibrosis disease. At present, studies related to silicosis are increasing, but the pathogenesis of silicosis still is not clear. In recent years, more and more studies have suggested that the Wnt signaling pathway could participate in the pathogenesis of silicosis fibrosis. In the study, we explored the mechanism of the Wnt signaling pathway in the pathogenesis of silicosis fibrosis and evaluated the effect of XAV‐939 treatment epithelial‐mesenchymal transformation (EMT) induced by silica. In addition, the results showed that EMT and activation of the Wnt signaling pathway would occur after stimulation of silica or TGF‐β1. However, after treatment with the Wnt signaling pathway inhibitor XAV‐939, EMT was reversed and the expression of the β‐catenin decreased. These results suggested that the Wnt signaling pathway is associated with EMT induced by silica and it could be a potential target for the treatment of silicosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Xinxiang Medical University, Xinxiang, China.
- Department of Chronic Disease Prevention, Zhengzhou Erqi District Center for Disease Control and Prevention, Zhengzhou, China.
- School of Public Health, North China University of Science and Technology, Tangshan, China.
Förderung
- National Natural Science and Technology Foundation Project
- Hebei Postgraduate
- Innovation Subsidy Project
- Key Scientific Research Projects of Higher
- Education Institutions in Henan Province
- Graduate Research and Innovation Support Program of grade 2020
- Xinxiang Medical University, Xinxiang
- Xinxiang Medical University
Zitieren
APA
Lv, Z., Xu, H., Si, X., Xu, S., Li, X., Li, N., Zhou, Q., Chang, M., Yao, S., & Li, H. (2023). XAV‐939 inhibits epithelial‐mesenchymal transformation in pulmonary fibrosis induced by crystalline silica via the Wnt signaling pathway. Environmental Toxicology, 38(2), 460-471. https://doi.org/10.1002/tox.23693
Vancouver
Lv Z, Xu H, Si X, Xu S, Li X, Li N, et al. XAV‐939 inhibits epithelial‐mesenchymal transformation in pulmonary fibrosis induced by crystalline silica via the Wnt signaling pathway. Environmental Toxicology. 2023;38(2):460-471. doi:10.1002/tox.23693
BibTeX
@article{Lv2023,
author = {Lv, Zhihao and Xu, Hao and Si, Xuezhe and Xu, Shushuo and Li, Xinxiao and Li, Ning and Zhou, Qiang and Chang, Meiyu and Yao, Sanqiao and Li, Haibin},
title = {XAV‐939 inhibits epithelial‐mesenchymal transformation in pulmonary fibrosis induced by crystalline silica via the Wnt signaling pathway},
journal = {Environmental Toxicology},
year = {2023},
volume = {38},
number = {2},
pages = {460--471},
doi = {10.1002/tox.23693}
}
EUVIMED